Gilead Wins CV Therapeutics Bid; Higher Bid Coming? (GILD, CVTX)
Gilead Sciences, Inc. (Nasdaq: GILD) has agreed to buy CV Therapeutics, Inc. (Nasdaq: CVTX) for $20.00 per share in cash. (more...) ...Read Full Story »
Posts related to ‘CVTX’
Read Full Story »
CV Therapeutics Next In Bio-Health Merger Line (CVTX)
CV Therapeutics, Inc. (NASDAQ: CVTX) is seeing a surge in its shares this morning. It looks like CV is the next biotech merger target now that Astellas Pharma Inc. submitted ...Read Full Story »
Top Pre-Market Analyst Downgrades (ACF, CLF, CVTX, PFE, SNY, THQI)
These are some of the top analyst downgrades we have seen this Friday morning:Americredit (ACF) Raised to Market Perform at FBR.Cliff’s Natural resources (CLF) Cut to Market Perform at FBR.CV ...Read Full Story »
Biotech Busine$$ Daily (ACAD, AMLN, CVTX, HALO, KOSN, MCU, NVAX, POZN, REGN, SIRT)
If you thought biotech news was getting quiet going into earnings season, think again.Acadia Pharmaceuticals Inc. (ACAD) presents Phase II data on pimavanserin, a treatment for Parkinson’s disease psychosis (PDP) ...Read Full Story »
CV Therapeutics Soars on TPG-Axon Financing (CVTX)
CV Therapeutics, Inc. (NASDAQ: CVTX) has secured a deal with TPG-Axon Capital, where it will receive up to $185 million in exchange for the rights to 50% of CV Therapeutics' ...Read Full Story »
Biotech Busine$$ Daily (ALKS, CADX, CVTX, MNKD, GNBT, PPHM)
Alkermes (NASDAQ: ALKS) and Johnson & Johnson Pharmaceutical Research and Developed today submitted paperwork seeking approval of their partnership drug, RISPERDAL CONSTA, to be allowed for treatment of bipolar disorder ...Read Full Story »
The 52-Week Low Club (NT)(DY)(GCI)(ADSK)(CVTX)
Dycom Industries (DY) Posts loss on lawsuit settlement. Falls to $11.88 from 52-week high of $34.13.Nortel (NT) Big loss and lay-offs. Down to $9.67 from 52-week high of $30.27.Journal Register ...Read Full Story »
CV Therapeutics Earnings Overshadows Takeover Spec
Posted by Thomas Catino Ant&SonsShares of CV Therapeutics Inc. (CVTX) are slumping, down $.60, or 5.52%, to $10.26 on moderate volume. It's been a volatile ride for the stock that ...Read Full Story »
Pre-Market Stock News (July 10, 2007)
(AA) Alcoa $0.81 EPS vs $0.81e; will likely have to sweeten Alcan bid before getting any approval from Alcan.(BOT) CBOT holders approve the CME merger offer.(CACS) Carrier Access lowered guidance.(CAKE) ...Read Full Story »
Pre-Market Stock News (June 18, 2007)
(AA) An ALCOA bid from BHP may be kindled according to numerous M&A reports.(ADVNA) Advanta trades ex-split to reflect a 3-2 stock split.(AGU) Agrium said earnings will be at or ...Read Full Story »
Cramer Speculates in CV Therapeutics (CVTX)
On tonight's Mad Money on CNBC, Jim Cramer had his normal 'Speculation Friday' and talked CV Therapeutics (CVTX) for a speculative biotech in with Acadia (ACAD) and Nastech (NSTK). Cramer ...Read Full Story »
-
Categories:
- 24/7 Wall St. Wire (2191)
- Accounting (227)
- Activist Investor (209)
- ADR (491)
- Aerospace (104)
- After-Hours Activity (95)
- Agriculture (240)
- Airlines (279)
- Analyst Calls (2549)
- Annual Report (50)
- Apparel (188)
- Austerity (17)
- auto (11)
- Autos (1097)
- Bait Shop (91)
- Banking (1522)
- Bankruptcy (174)
- Biotech (692)
- Blogs (5)
- Bonds (351)
- Brokerage Firms (411)
- Buffett (281)
- Buffett Holdings (29)
- business and finance (24)
- Business Services (153)
- Cable Companies (113)
- Calendar (201)
- Casinos (64)
- Charts (99)
- China (785)
- Commodities (557)
- Compensation (262)
- Conglomerates (398)
- Consumer Electronics (958)
- Consumer Goods (407)
- Corporate Governance (368)
- Cramer (728)
- Cult Stock (176)
- Currency (110)
- Defense (70)
- Defensive Stocks (107)
- Dividend (444)
- Drug companies (233)
- Earnings (2696)
- Earnings Warning (409)
- Economy (2229)
- Editor's Picks (417)
- Emerging Markets (188)
- Entertainment (509)
- ETF (513)
- Exchange (34)
- Exchange News (107)
- FDA (81)
- Financial Stocks (1135)
- Food (545)
- General (3595)
- Green Biz (818)
- Alternative Energy (781)
- Hardware (187)
- Healthcare (146)
- HI/LOW (644)
- Housing (607)
- Index (235)
- Industry (106)
- Technology (79)
- Semiconductors (24)
- Technology (79)
- Infrastructure (179)
- Insider Activity (194)
- International Markets (1898)
- Internet (1597)
- Interview (51)
- IPOs (902)
- Labor & Unions (402)
- Large Cap Stocks (121)
- Law (364)
- Luxury (140)
- Management Change (579)
- Market Close (111)
- Market Open (109)
- Market Roundups (31)
- Media (797)
- Medical (215)
- Mergers and Buy Outs (1753)
- Metals (409)
- Micro Cap (7)
- Most Actives (31)
- Mutual Funds (198)
- Nanotech (8)
- Newsletter (7)
- Nuclear (71)
- Oil & Gas (1636)
- Old Media (195)
- Options (91)
- OTC (23)
- PC Companies (563)
- Personal Finance (52)
- Pharmaceuticals (204)
- Politics (505)
- Polls (18)
- Pre-Market Activity (728)
- Press Digest (1280)
- Private Equity (402)
- Product Review (58)
- Regulation (428)
- REIT (78)
- Research (1447)
- Restatements (21)
- Retail (1163)
- Rumors (788)
- Satellite (263)
- SEC (154)
- Secondary Offering (482)
- Semiconductor (613)
- Shareholder Issues (424)
- Short Interest (309)
- Small Cap Stocks (20)
- Software (703)
- Special Report (52)
- Stock Buybacks (157)
- Stock Splits (53)
- Tax (75)
- Technical Analysis (94)
- Technology Companies (1234)
- Telecom (597)
- The Day (78)
- The Week (132)
- Tobacco (45)
- Trading Alert (917)
- Transports (231)
- Turnarounds (195)
- TV (69)
- Utilities (263)
- Value Investing (305)
- Video Games (189)
- Water (53)
- WiMAX (156)
- Wireless (896)
